Sphingosine kinase 1 and cancer: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Zhang, Yun ^a   Wang, Yan ^b   Wan, Zhi ^a   Liu, Shiping ^a   Cao, Yu ^a   Zeng, Zhi ^a  

^a SICHUAN UNIVERSITY   (China)

^b JILIN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; SPHINGOSINE KINASE 1;

BENIGN TUMOR; BREAST CANCER; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; DISEASE ASSOCIATION; ENZYME ANALYSIS; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE EXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVIEW; STOMACH CANCER; SURVIVAL TIME; SYSTEMATIC REVIEW; TONGUE CARCINOMA;

ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; NEOPLASMS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROPORTIONAL HAZARDS MODELS; PUBLICATION BIAS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84896385011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090362     Document Type: Review

References (53)

1. Ipatova OM, Torkhovskaya TI, Zakharova TS, Khalilov EM (2006) Sphingolipids and cell signaling: Involvement in apoptosis and atherogenesis. Biochemistry (Moscow) 71: 713-722. (Pubitemid 44092034)
2. Ricci C, Onida F, Ghidoni R (2006) Sphingolipid players in the leukemia arena. Biochimica et biophysica acta 1758: 2121-2132. (Pubitemid 44879363)
3. Cuvillier O (2002) Sphingosine in apoptosis signaling. Biochimica et biophysica acta 1585: 153-162.
4. Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, et al. (2006) Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochimica et biophysica acta 1758: 1864-1884. (Pubitemid 44879367)
5. Selvam SP, Ogretmen B (2013) Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance. Handbook of experimental pharmacology: 3-27.
6. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nature reviews Molecular cell biology 9: 139-150. (Pubitemid 351158911)
7. Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S (2008) Targeting SphK1 as a new strategy against cancer. Current drug targets 9: 662.
8. Blondeau N, Lai Y, Tyndall S, Popolo M, Topalkara K, et al. (2007) Distribution of sphingosine kinase activity and mRNA in rodent brain. Journal of neurochemistry 103: 509-517. (Pubitemid 47498013)
9. Fukuda Y, Kihara A, Igarashi Y (2003) Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1. Biochemical and Biophysical Research Communications 309: 155-160. (Pubitemid 36999771)
10. Murate T, Banno Y, K TK, Watanabe K, Mori N, et al. (2001) Cell type-specific localization of sphingosine kinase 1a in human tissues. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 49: 845-855.
11. Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, et al. (2005) SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. The Journal of biological chemistry 280: 37118-37129. (Pubitemid 41587796)
12. Vadas M, Xia P, McCaughan G, Gamble J (2008) The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction? Biochimica et biophysica acta 1781: 442-447.
13. Akao Y, Banno Y, Nakagawa Y, Hasegawa N, Kim TJ, et al. (2006) High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation. Biochem Biophys Res Commun 342: 1284-1290.
14. Brizuela L, Ader I, Mazerolles C, Bocquet M, Malavaud B, et al. (2012) First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancer. Molecular cancer therapeutics 11: 1841-1851.
15. Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, et al. (2009) Role for sphingosine kinase 1 in colon carcinogenesis. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 23: 405-414.
16. Johnson KR, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, et al. (2005) Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 53: 1159-1166.
17. Van Brocklyn JR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, et al. (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. Journal of Neuropathology & Experimental Neurology 64: 695-705. (Pubitemid 41177111)
18. Li J, Guan HY, Gong LY, Song LB, Zhang N, et al. (2008) Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival. Clinical cancer research : an official journal of the American Association for Cancer Research 14: 6996-7003.
19. Pyne S, Edwards J, Ohotski J, Pyne NJ (2012) Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers. Frontiers in oncology 2: 168.
20. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in medicine 17: 2815-2834. (Pubitemid 28562978)
21. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16.
22. Bayerl MG, Bruggeman RD, Conroy EJ, Hengst JA, King TS, et al. (2008) Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions. Leukemia & lymphoma 49: 948-954. (Pubitemid 351942749)
23. Ruckhaberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, et al. (2008) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast cancer research and treatment 112: 41-52.
24. Li W, Yu CP, Xia JT, Zhang L, Weng GX, et al. (2009) Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clinical cancer research : an official journal of the American Association for Cancer Research 15: 1393-1399.
25. Erez-Roman R, Pienik R, Futerman AH (2010) Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochem Biophys Res Commun 391: 219-223.
26. Guan HY (2010) Molecular Mechanism of Anti•-apoptotic Activity of Sphingosine Kinase 1 in Glioma and Clinical Significance. Microbiology. Guangzhou: Sun Yat-Sen University.pp.68.
27. Jing H (2010) Sphingosine kinases 1 and sphingosine-1-posphate receptors mRNA and protein expression in colorectal adenocarcinoma. Digestive medicine. Guang Xi: Guangxi Medical University. pp. 54.
28. Knapp P, Baranowski M, Knapp M, Zabielski P, Blachnio-Zabielska AU, et al. (2010) Altered sphingolipid metabolism in human endometrial cancer. Prostaglandins & other lipid mediators 92: 62-66.
29. Liu G, Zheng H, Zhang Z, Wu Z, Xiong H, et al. (2010) Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy. BMC cancer 10: 495.
30. Malavaud B, Pchejetski D, Mazerolles C, de Paiva GR, Calvet C, et al. (2010) Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens. European journal of cancer 46: 3417-3424.
31. Watson C, Long JS, Orange C, Tannahill CL, Mallon E, et al. (2010) High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. The American journal of pathology 177: 2205-2215.
32. Yi Z, Yan Z, Shu-shu W, Qing-qiu C, Jun J (2010) Expression of sphingosine kinase 1 in atypical hyperplasia of the breast and breast cancer and its significance. Chin J Breast Dis(Electronic Edit]on) 4: 200-205.
33. Xu Z, Guan HY, Fei YC, Li ZQ, Li SS, et al. (2010) Clinical significance of the expression of sphingolipids kinase-1 in neuroblastoma. Chin J Exp Surg 27: 1413-1414.
34. Guan H, Liu L, Cai J, Liu J, Ye C, et al. (2011) Sphingosine kinase 1 is overexpressed and promotes proliferation in human thyroid cancer. Molecular endocrinology 25: 1858-1866.
35. Pan J, Tao YF, Zhou Z, Cao BR, Wu SY, et al. (2011) An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma. Journal of translational medicine 9: 157.
36. Shirai K, Kaneshiro T, Wada M, Furuya H, Bielawski J, et al. (2011) A role of sphingosine kinase 1 in head and neck carcinogenesis. Cancer prevention research 4: 454-462.
37. Sinha UK, Schorn VJ, Hochstim C, Chinn SB, Zhu S, et al. (2011) Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Head & neck 33: 178-188.
38. Zhuge Y, Tao H, Wang Y (2011) [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer]. Zhonghua yi xue za zhi 91: 2765-2768.
39. Bao M, Chen Z, Xu Y, Zhao Y, Zha R, et al. (2012) Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 32: 331-338.
40. Shan HX, Huang GQ, Cai HX, Zhu ZQ. (2012) Expression of SphKl in gastric cancer and its clinical significance. Chinese Clinical Oncology 17: 1076-1005.
41. Kalari S, Moolky N, Pendyala S, Berdyshev EV, Rolle C, et al. (2012) Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylation. PloS one 7: e45330.
42. Liu Y, Li K, Xu SN, LIU WJ, Hou XF, et al. (2012) Relationships between SphK1 and esophageal cancer invasion and metastasis. Journal of Shandong University (Health Science) 50: 21-24,28.
43. Nunes J, Naymark M, Sauer L, Muhammad A, Keun H, et al. (2012) Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection. British journal of cancer 106: 909-915.
44. Ohotski J, Long JS, Orange C, Elsberger B, Mallon E, et al. (2012) Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer. British journal of cancer 106: 1453-1459.
45. Su Y, Huang J, Liu S, Huang J, Zhong Y, et al. (2012) The expression and clinical significance of SphK1 and nuclear factor-kappaB p65 in human colon carcinoma. Zhonghua nei ke za zhi [Chinese journal of internal medicine] 51: 220-224.
46. Yue ZW, Cao XP. Wang SB, Zhang K. (2012) Expression of sphingosine kinase 1 in tongue squamous cell carcinoma and its down regulation on Tca 8113 cell migration. J Pract Stomatol 28: 735-739.
47. Georgiou GK, Igglezou M, Sainis I, Vareli K, Batsis H, et al. (2013) Impact of breast cancer surgery on angiogenesis circulating biomarkers: a prospective longitudinal study. World journal of surgical oncology 11: 213.
48. Harris BN, Masood R and Sinha UK (2013) Sphk1 Expression and Survival Outcomes in Squamous Cell Carcinoma of the Oral Cavity. Journal of Cancer Therapy 04: 704-708.
49. Liu S, Su Y, Qin MB, Mao YB, Huang JA, et al. (2013) Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. International journal of oncology 42: 617-626.
50. Zhang Lj, Xia JT, Zhang LJ, Jian WH, Lai YY, et al. (2013) RNA Interference Down-regurates SPHK1 Gene and Inhibits Proliferation Of Gastric Cancer Cel. Journal of Sun Yat-sen University (Meducak Sciences) 34: 321-325.
51. Ohotski J, Edwards J, Elsberger B, Watson C, Orange C, et al. (2013) Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1-phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor-positive breast cancer. International journal of cancer Journal international du cancer 132: 605-616.
52. Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, et al. (2013) Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models. Clinical cancer research : an official journal of the American Association for Cancer Research 19: 138-147.
53. Ruckhaberle E, Karn T, Denkert C, Loibl S, Ataseven B, et al. (2013) Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer. Journal of cancer research and clinical oncology 139: 1681-1689.